Stock listing
gettex:V30 Apotea AB Aktie
German listing (gettex) of Apotea AB · home listing Stockholm:APOTEA
Follow Apotea AB into a list and get an email when it puts out news.
Home listing price · OMXSTO:APOTEA
101.20 SEK -0.10 (-0.1%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:APOTEA
- Day range
- 100.20 – 101.70 SEKNov 20, 2026
- Volume
- 94,277 sharesNov 20, 2026
- Market cap
- 10.53B SEKAt the close on Nov 20, 2026 · price × 104.1M shares outstanding
- 52-week range
- 54.42 – 106.50 SEKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- 20.08M SEKMedian day 148,816 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Stockholm:APOTEA · Home | 101.20 SEK | -0.10 (-0.1%) | 94,277 | 101.20 | 101.70 | 100.20 | 101.30 | Close on Nov 20, 2026 |
| Frankfurt:V30 | €8.995 EUR | -0.085 (-0.9%) | — | €9.05 | €9.05 | €8.995 | €9.08 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OMXSTO:APOTEA · SEK, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 101.20 | -0.10 | -0.1% | 101.20 | 101.70 | 100.20 | 94,277 | |
| 101.30 | +0.10 | +0.1% | 101.00 | 103.30 | 100.40 | 373,918 | |
| 101.20 | -0.60 | -0.6% | 101.80 | 102.50 | 100.60 | 93,454 | |
| 101.80 | +1.40 | +1.4% | 100.00 | 102.50 | 100.00 | 129,321 | |
| 100.40 | +0.60 | +0.6% | 99.00 | 100.90 | 98.75 | 206,784 | |
| 99.80 | -1.90 | -1.9% | 102.40 | 102.60 | 98.90 | 263,978 | |
| 101.70 | -2.60 | -2.5% | 106.00 | 106.50 | 100.50 | 303,144 | |
| 104.30 | +1.30 | +1.3% | 103.70 | 104.90 | 101.10 | 313,176 | |
| 103.00 | +7.40 | +7.7% | 95.00 | 105.50 | 94.00 | 1,197,799 | |
| 95.60 | +1.35 | +1.4% | 94.25 | 95.90 | 93.80 | 234,977 | |
| 94.25 | +0.25 | +0.3% | 93.85 | 94.50 | 93.05 | 161,302 | |
| 94.00 | +1.85 | +2.0% | 92.00 | 94.00 | 91.00 | 223,428 | |
| 92.15 | 0.00 | 0.0% | 92.35 | 92.65 | 91.90 | 95,292 | |
| 92.15 | -0.65 | -0.7% | 92.80 | 93.90 | 91.80 | 137,428 | |
| 92.80 | +0.70 | +0.8% | 92.10 | 93.20 | 91.15 | 142,366 | |
| 92.10 | +0.55 | +0.6% | 91.35 | 92.35 | 90.80 | 103,126 | |
| 91.55 | +0.70 | +0.8% | 90.90 | 92.40 | 90.75 | 1,126,324 | |
| 90.85 | +0.05 | +0.1% | 90.80 | 91.25 | 89.65 | 162,161 | |
| 90.80 | +0.65 | +0.7% | 90.15 | 90.80 | 89.10 | 432,542 | |
| 90.15 | +0.85 | +1.0% | 90.05 | 90.15 | 87.90 | 169,884 | |
| 89.30 | -0.70 | -0.8% | 90.00 | 91.25 | 88.80 | 220,094 | |
| 90.00 | -0.60 | -0.7% | 90.20 | 91.35 | 89.80 | 880,592 | |
| 90.60 | +0.95 | +1.1% | 88.70 | 91.35 | 88.70 | 248,740 | |
| 89.65 | +2.30 | +2.6% | 87.40 | 89.65 | 87.35 | 268,243 | |
| 87.35 | +0.85 | +1.0% | 86.65 | 87.35 | 86.45 | 105,859 | |
| 86.50 | +0.80 | +0.9% | 85.65 | 87.50 | 85.05 | 157,504 | |
| 85.70 | +0.70 | +0.8% | 85.00 | 86.40 | 84.80 | 103,935 | |
| 85.00 | 0.00 | 0.0% | 85.15 | 86.40 | 85.00 | 117,975 | |
| 85.00 | +2.45 | +3.0% | 82.45 | 85.50 | 82.30 | 214,390 | |
| 82.55 | +0.50 | +0.6% | 81.90 | 83.10 | 81.60 | 57,860 | |
| 82.05 | +0.50 | +0.6% | 81.50 | 83.40 | 81.50 | 101,765 | |
| 81.55 | -0.50 | -0.6% | 81.85 | 83.20 | 80.75 | 229,199 | |
| 82.05 | -1.05 | -1.3% | 83.10 | 83.75 | 81.85 | 148,087 | |
| 83.10 | -2.15 | -2.5% | 85.35 | 85.45 | 83.10 | 312,672 | |
| 85.25 | -1.75 | -2.0% | 87.00 | 88.15 | 85.10 | 576,689 | |
| 87.00 | +0.90 | +1.0% | 85.95 | 87.00 | 85.50 | 211,918 | |
| 86.10 | +2.40 | +2.9% | 83.70 | 86.10 | 83.70 | 334,463 | |
| 83.70 | +1.60 | +1.9% | 82.30 | 83.75 | 81.80 | 104,431 | |
| 82.10 | +0.20 | +0.2% | 81.85 | 83.40 | 81.50 | 144,375 | |
| 81.90 | -2.10 | -2.5% | 83.95 | 85.15 | 81.75 | 138,270 | |
| 84.00 | +2.70 | +3.3% | 81.30 | 84.45 | 81.25 | 181,175 | |
| 81.30 | +1.30 | +1.6% | 80.00 | 81.50 | 79.85 | 158,229 | |
| 80.00 | +1.50 | +1.9% | 78.30 | 82.30 | 78.00 | 451,904 | |
| 78.50 | +2.30 | +3.0% | 76.10 | 79.00 | 76.05 | 744,594 | |
| 76.20 | +1.00 | +1.3% | 75.20 | 76.30 | 74.80 | 84,320 | |
| 75.20 | +0.80 | +1.1% | 74.25 | 75.90 | 74.00 | 115,198 | |
| 74.40 | +0.40 | +0.5% | 74.00 | 75.10 | 73.60 | 98,441 | |
| 74.00 | -0.15 | -0.2% | 74.50 | 75.15 | 74.00 | 77,366 | |
| 74.15 | -1.80 | -2.4% | 75.75 | 76.30 | 74.10 | 128,103 | |
| 75.95 | -1.00 | -1.3% | 76.95 | 78.25 | 75.70 | 128,686 | |
| 76.95 | -0.05 | -0.1% | 77.15 | 77.40 | 75.60 | 80,702 | |
| 77.00 | -0.30 | -0.4% | 77.30 | 77.30 | 76.80 | 38,294 | |
| 77.30 | -0.85 | -1.1% | 78.55 | 79.00 | 77.20 | 77,567 | |
| 78.15 | +2.00 | +2.6% | 76.00 | 78.55 | 75.40 | 118,889 | |
| 76.15 | -0.35 | -0.5% | 77.00 | 77.35 | 76.00 | 162,957 | |
| 76.50 | -1.25 | -1.6% | 77.75 | 77.75 | 76.30 | 98,384 | |
| 77.75 | +1.40 | +1.8% | 76.50 | 77.90 | 76.30 | 318,914 | |
| 76.35 | -0.60 | -0.8% | 76.70 | 77.95 | 76.05 | 144,054 | |
| 76.95 | +1.65 | +2.2% | 74.30 | 77.00 | 74.30 | 102,680 | |
| 75.30 | 0.00 | 0.0% | 75.50 | 75.90 | 74.85 | 94,466 | |
| 75.30 | +1.80 | +2.4% | 73.75 | 75.70 | 73.55 | 178,565 | |
| 73.50 | -0.65 | -0.9% | 74.10 | 74.10 | 73.50 | 73,828 | |
| 74.15 | 0.00 | 0.0% | 74.20 | 75.00 | 73.50 | 87,654 | |
| 74.15 | +0.25 | +0.3% | 73.85 | 74.65 | 73.35 | 149,544 |
- Ticker
- gettex:V30
- Asset type
- Stock
- Sector
- Retail & consumer services
- Industry
- Retail & e-commerce
- Exchange
- gettex
- Currency
- EUR
What changed lately
Latest news release · Jul 17, 2026
Apotea: Continued strong profitability and stable growth
Latest earnings call · Nov 5, 2026
Apotea (Stockholm:APOTEA) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Jul 17, 2026
Q2 2026 Earnings Presentation
Earnings · 12 slides
Latest news
Apotea: Continued strong profitability and stable growth
Jul 17, 2026
Closed 79.50 (+7.9%) on Jul 17, 2026
APOTEA: Q1 2026 delivered strong growth, higher margins, and a solid net cash position
Apr 29, 2026
Closed 75.60 (+12.8%) on Apr 29, 2026
Apotea publishes annual and sustainability report for the financial year 2025
Apr 17, 2026
Closed 66.80 (+0.5%) on Apr 17, 2026
APOTEA: Q4 revenue grew 7% but margins fell on campaign intensity and Varberg ramp-up costs
Feb 4, 2026
Closed 60.86 (-1.9%) on Feb 5, 2026
Apotea has recruited Joanna Hummel to accelerate the company’s growth initiatives
Jan 28, 2026
Closed 62.94 (+1.2%) on Jan 28, 2026
Apotea Preliminary Q4 Oper Margin Below Targets At 1.3%
Jan 21, 2026
Closed 65.00 (-21.9%) on Jan 21, 2026
Update regarding the fourth quarter of 2025
Jan 20, 2026
Closed 65.00 (-21.9%) on Jan 21, 2026
Invitation to Apotea’s presentation of the year-end report 2025
Dec 18, 2025
Closed 93.19 (+0.1%) on Dec 18, 2025
Apotea Board Member Sells SEK 43.4 Mln Of Shares On Dec 4
Dec 4, 2025
Closed 87.13 (-0.3%) on Dec 4, 2025
Apotea AB on 6ix
- Industry
- Retail & e-commerce
- News releases
- 9 in the last 12 months · 14 in all · newest Jul 17, 2026 · oldest 2025
- Calls
- 8 calls with a replay · 8 with a transcript · latest Nov 5, 2026
- Decks
- 7 decks · latest Jul 17, 2026
Where Apotea AB is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Stockholm:APOTEA · Home listing | Stockholm | Sweden | SEK |
| gettex:V30 · This page | gettex | Germany | EUR |
| Tradegate:V30 | Tradegate | Germany | EUR |
| Frankfurt:V30 | Frankfurt | Germany | EUR |
| Stuttgart:V30 | Stuttgart | Germany | EUR |
| LS Exchange:A40WTZ | LS Exchange | Germany | EUR |
| Dusseldorf:V30 | Dusseldorf | Germany | EUR |
| Munich:V30 | Munich | Germany | EUR |
| Lang & Schwarz:A40WTZ | Lang & Schwarz | Germany | EUR |
| Turquoise:APOTES | Turquoise | United Kingdom | SEK |
Valuation
P/E 40.7× against a median of 15.5×: the highest of 10 Retail & e-commerce companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- 10.42B SEK
- P/E
- 40.7×
- EV/sales
- 1.3×
- EV/EBITDA
- 18.9×
- Price/book
- 10.2×
- Gross margin
- 26.9%
- Operating margin
- 4.3%
- Net margin
- 3.3%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Retail & e-commerce: the 10 companies nearest in size, of 506 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Apotea AB · OMXSTO:APOTEA | US$1.03B | US$1.02B | 40.7× | 1.3× | 18.9× | 10.2× | 3.3% | 0.0× | n/a |
| Magazine Luiza S.A. · BMFBOVESPA:MGLU3 | US$1.07B | US$2.21B | n/a | 0.3× | 6.0× | 0.6× | −0.0% | 0.8× | n/a |
| Dis-Chem Pharmacies Limited · JSE:DCP | US$1.06B | US$1.41B | 19.0× | 0.6× | 7.6× | 3.1× | 2.3% | 1.1× | n/a |
| Moonpig Group PLC · LSE:MOON | US$1.05B | US$1.19B | 15.5× | 2.4× | 8.7× | n/a | 13.9% | n/a | n/a |
| Pet Valu Holdings Ltd. · TSX:PET | US$1.04B | US$1.59B | 14.8× | 1.9× | 8.6× | 16.1× | 8.4% | 8.8× | 0.40 |
| PT Daya Intiguna Yasa Tbk · IDX:MDIY | US$1.03B | US$1.15B | 15.5× | 2.2× | 7.3× | 4.1× | 13.0% | 0.6× | n/a |
| FPT Digital Retail JSC · HOSE:FRT | US$1.03B | US$579.8M | 19.5× | 0.2× | 5.6× | 5.0× | 2.1% | 0.0× | n/a |
| PT MAP Aktif Adiperkasa Tbk · IDX:MAPA | US$973.3M | US$1.04B | 8.8× | 0.9× | 4.0× | 1.7× | 9.2% | 0.3× | n/a |
| Truworths International Limited · JSE:TRU | US$971.4M | US$1.20B | 6.4× | 1.0× | 4.9× | 1.7× | 12.2% | 0.7× | n/a |
| PT Mitra Adiperkasa Tbk · IDX:MAPI | US$959.9M | US$1.14B | 6.8× | 0.4× | 2.4× | 1.1× | 5.2% | 0.6× | n/a |
| Boozt AB · OMXSTO:BOOZT | US$955.1M | US$1.02B | 29.2× | 1.2× | 13.1× | 3.6× | 3.8% | 0.4× | n/a |
| Median of the others | US$1.03B | US$1.17B | 15.5× | 0.9× | 6.7× | 3.1× | 6.8% | 0.6× | 0.40 |
Forecasts
Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.
- Price target
- 105.50 SEK · Analysts' mean
- EPS, year to Dec 2026
- 2.92 · 2 analysts
- Revenue, year to Dec 2026
- 8.08B · 2 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Pär Svärdson | CEO |
| Johan Mårild | CFO |
| Sarah Ahnström | Deputy CEO/COO |
| Joanna Hummel | Chief Growth Officer |
| Stefan Eriksson | Deputy CEO/Organization and people |
Board
| Director | Role |
|---|---|
| Joanna Hummel | Chief Growth Officer |
| Pär Svärdson | CEO |
Events
- Next results
- Feb 4, 2027 (expected)
Calls
| Call | When | Status |
|---|---|---|
| Apotea (Stockholm:APOTEA) Q3 2026 Earnings Call | Thu, Nov 05, 2026 · 3:30 AM ET | Replay |
| Apotea (Stockholm:APOTEA) Q2 2026 Earnings Call | Fri, Jul 17, 2026 · 3:30 AM ET | Replay |
| Apotea (Stockholm:APOTEA) Q1 2026 Earnings Call | Wed, Apr 29, 2026 · 3:30 AM ET | Replay |
| Apotea (Stockholm:APOTEA) Q4 2025 Earnings Call | Wed, Feb 04, 2026 · 3:30 AM ET | Replay |
| Apotea (Stockholm:APOTEA) Q3 2025 Earnings Call | Thu, Nov 06, 2025 · 3:30 AM ET | Replay |
| Apotea (Stockholm:APOTEA) Q2 2025 Earnings Call | Fri, Jul 18, 2025 · 3:30 AM ET | Replay |
| Apotea (Stockholm:APOTEA) Q1 2025 Earnings Call | Thu, May 08, 2025 · 3:30 AM ET | Replay |
| Apotea (Stockholm:APOTEA) Q4 2024 Earnings Call | Thu, Feb 06, 2025 · 3:30 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 5, 2026 · Before open | +7.7% |
| Q2 2026 | Jul 17, 2026 · Before open | +7.9% |
| Q1 2026 | Apr 29, 2026 · Before open | +12.8% |
| Q4 2025 | Feb 4, 2026 · Before open | +4.8% |
| Q3 2025 | Nov 6, 2025 · Before open | +9.8% |
| Q2 2025 | Jul 18, 2025 · After close | +8.0% |
| Q1 2025 | May 8, 2025 · Before open | +4.0% |
| Q4 2024 | Feb 6, 2025 | +6.6% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2026 Earnings Presentation | Earnings | 12 slides | Jul 17, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 10 slides | Apr 29, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 14 slides | Feb 4, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 11 slides | Nov 6, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 11 slides | Jul 18, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 10 slides | May 8, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 14 slides | Feb 6, 2025 |
Financials
Annual, in SEK
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7.20B | 6.54B | 5.45B | 4.88B | 4.56B |
| Cost of revenue | 5.27B | 4.75B | 4.00B | 3.61B | 3.81B |
| Gross profit | 1.94B | 1.79B | 1.45B | 1.27B | 750.3M |
| Research and development | 597.6K | ||||
| Operating income | 298.2M | 265.8M | 113.6M | 49.0M | 133.6M |
| Depreciation and amortization | 162.3M | 129.6M | 112.7M | 70.0M | 49.9M |
| EBITDA | 460.5M | 395.4M | 226.3M | 119.0M | 183.5M |
| Interest expense | 12.0M | 5.30M | 6.30M | 3.80M | |
| Income before tax | 289.8M | 264.7M | 108.7M | 31.0M | 130.4M |
| Income tax | 63.5M | 52.7M | 26.4M | 12.7M | 25.9M |
| Net income | 228.7M | 214.9M | 87.0M | 19.9M | 104.5M |
| Earnings per share, basic | 2.20 | 2.09 | 0.85 | 0.19 | 1.03 |
| Earnings per share, diluted | 2.20 | 2.09 | 0.85 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash and equivalents | 30.6M | 27.3M | 19.1M | 18.2M | 81.4M |
| Receivables | 355.4M | 358.8M | 289.4M | 246.0M | 230.7M |
| Inventory | 651.9M | 562.3M | 410.1M | 390.0M | 338.3M |
| Current assets | 1.12B | 1.02B | 781.5M | 721.3M | 710.8M |
| Property, plant and equipment | 505.8M | 388.0M | 299.2M | ||
| Goodwill | 30.5M | 32.0M | 32.5M | 57.5M | 5.48M |
| Total assets | 1.98B | 1.63B | 1.34B | 1.25B | 1.02B |
| Accounts payable | 584.1M | 559.4M | 546.1M | 463.8M | 435.7M |
| Current liabilities | 871.5M | 880.8M | 756.7M | 716.4M | 559.5M |
| Total debt | 331.0M | 21.8M | 25.9M | 332.7M | 144.3M |
| Total liabilities | 1.12B | 991.7M | 911.4M | 897.5M | 685.0M |
| Shareholders' equity | 844.0M | 615.2M | 403.7M | 327.5M | 339.8M |
| Shares outstanding | 104.1M | 102.6M | 104.1M | 104.1M | 101.9M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash from operations | 333.3M | 206.2M | 215.8M | 31.5M | 227.3M |
| Capital spending | -213.0M | -162.8M | -119.9M | -142.1M | -81.5M |
| Free cash flow | 120.3M | 43.4M | 95.9M | -110.6M | 145.8M |
| Cash from investing | -214.5M | -163.7M | -121.6M | -141.4M | -81.6M |
| Cash from financing | -115.3M | -34.2M | -93.3M | 46.3M | -78.4M |
| Dividends paid | -28.5M | -28.4M | |||
| Change in cash | 3.50M | 8.30M | 900.0K | -63.5M | 67.3M |
Cap table
Built by 6ix from Apotea AB’s releases
- Common shares
- 104,070,966
- Fully diluted
- 104,070,966
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 104,070,966 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 104,070,966 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Joanna Hummel | Chief Growth Officer · Since at least Jan 28, 2026 |
| Johan Mårild | CFO · Since at least Jul 17, 2026 |
| Pär Svärdson | CEO · Since at least Jul 17, 2026 |
| Sarah Ahnström | Deputy CEO/COO · Since at least Jul 17, 2026 |
| Stefan Eriksson | Deputy CEO/Organization and people · Since at least Jul 17, 2026 |
Log in to ask 6ix AI your own questions about Apotea AB.